Xeris Biopharma Holdings Inc (XERS)
3.285
+0.06
(+1.70%)
USD |
NASDAQ |
Nov 04, 13:02
Xeris Biopharma Holdings Max Drawdown (5Y): 96.22% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 96.22% |
| September 30, 2024 | 96.22% |
| August 31, 2024 | 96.22% |
| July 31, 2024 | 96.22% |
| June 30, 2024 | 96.22% |
| May 31, 2024 | 96.22% |
| April 30, 2024 | 96.22% |
| March 31, 2024 | 96.22% |
| February 29, 2024 | 96.22% |
| January 31, 2024 | 96.22% |
| December 31, 2023 | 96.22% |
| November 30, 2023 | 96.22% |
| October 31, 2023 | 96.22% |
| September 30, 2023 | 96.22% |
| August 31, 2023 | 96.22% |
| July 31, 2023 | 96.22% |
| June 30, 2023 | 96.22% |
| May 31, 2023 | 96.22% |
| April 30, 2023 | 96.22% |
| March 31, 2023 | 96.22% |
| February 28, 2023 | 96.22% |
| January 31, 2023 | 96.22% |
| December 31, 2022 | 95.81% |
| November 30, 2022 | 95.52% |
| October 31, 2022 | 95.52% |
| Date | Value |
|---|---|
| September 30, 2022 | 94.97% |
| August 31, 2022 | 94.97% |
| July 31, 2022 | 94.97% |
| June 30, 2022 | 94.56% |
| May 31, 2022 | 94.53% |
| April 30, 2022 | 94.53% |
| March 31, 2022 | 94.53% |
| February 28, 2022 | 94.53% |
| January 31, 2022 | 94.53% |
| December 31, 2021 | 94.53% |
| November 30, 2021 | 94.53% |
| October 31, 2021 | 94.53% |
| September 30, 2021 | 94.53% |
| August 31, 2021 | 94.53% |
| July 31, 2021 | 94.53% |
| June 30, 2021 | 94.53% |
| May 31, 2021 | 94.53% |
| April 30, 2021 | 94.53% |
| March 31, 2021 | 94.53% |
| February 28, 2021 | 94.53% |
| January 31, 2021 | 94.53% |
| December 31, 2020 | 94.53% |
| November 30, 2020 | 94.53% |
| October 31, 2020 | 94.53% |
| September 30, 2020 | 94.53% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
71.94%
Minimum
Nov 2019
96.22%
Maximum
Jan 2023
94.13%
Average
94.53%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Zoetis Inc | 46.52% |
| Zevra Therapeutics Inc | 99.27% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -43.11 |
| Beta (5Y) | 1.839 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 99.58% |
| Historical Sharpe Ratio (5Y) | -0.1946 |
| Historical Sortino (5Y) | -0.4218 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.45% |